Value proposition

Chr. Hansen has combined with Novozymes to become Novonesis: linkedin.com/company/novonesis. This global biosolutions company of 10,000 people is transforming how the world produces, consumes and lives. In 30-plus industries, its biosolutions help businesses meet their needs and the needs of our planet.

Chr. Hansen was founded in 1874 by the Danish pharmacist Christian D. A. Hansen who invented an industrial process to extract rennet for cheese making. The company was a microbial powerhouse that developed natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. Its unique microbial and fermentation technology platforms and collection of around 50,000 microbial strains helped it meet its commitment to grow a better world. Naturally.

In December 2022, Chr. Hansen and Novozymes entered into an agreement to create a leading global biosolutions partner by combining the two companies. The goal was to unleash the full potential of biosolutions and generate significant value for all stakeholders and society. The combination was completed on January 29, 2024, and Novonesis was born. The name means ‘a new beginning’ and is derived from the Greek word ‘genesis’. It reflects a new era where we’ll better our world with biology. You can find Novonesis on LinkedIn here: linkedin.com/company/novonesis.

Chr. Hansen A/S, part of Novonesis Group.

dairy, dietary supplements, bacteria, cultures, dairy cultures, enzymes, wine, wine ingredients, health, natural ingredients, probiotic, probiotics, fermentation, phytonutritients, meat, silage, and feed probiotics